Alcohol calibration of tests measuring skills related to car driving

详细信息    查看全文

• 作者：Stefan Jongen (1)
  Eric Vuurman (1)
  Jan Ramaekers (1)
  Annemiek Vermeeren (1)
  
• 关键词：Driving ; Alcohol ; Attention ; Psychomotor performance ; Cognition ; Psychometric tests
• 刊名：Psychopharmacology
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：231
• 期：12
• 页码：2435-2447
• 全文大小：
• 参考文献：1. Basner M,? Dinges DF (2011) Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss. Sleep 34(5):581-91
  2. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47(3):211-18 <a class="external" href="http://dx.doi.org/10.1111/j.2044-8341.1974.tb02285.x" target="_blank" title="It opens in new window">CrossRefa>
  3. Borkenstein F, Crowther RF, Shumate RP, Zeil WB, Zylman R (1964) The role of the drinking driver in traffic accidents. Indiana University, Bloomington
  4. Bosker WM, Kuypers KP, Conen S, Ramaekers JG (2010) Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss. Psychopharmacology 209(1):69-6 <a class="external" href="http://dx.doi.org/10.1007/s00213-009-1767-1" target="_blank" title="It opens in new window">CrossRefa>
  5. Boyle J, Danjou P, Alexander R, Calder N, Gargano C, Agrawal N, Murphy MG (2009) Tolerability, pharmacokinetics and night‐time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. Br J Clin Pharmacol 67(2):180-90 <a class="external" href="http://dx.doi.org/10.1111/j.1365-2125.2008.03331.x" target="_blank" title="It opens in new window">CrossRefa>
  6. Brasser SM, McCaul ME, Houtsmuller EJ (2004) Alcohol effects during acamprosate treatment: a dose–response study in humans. Alcoholism: Clin Exp Res 28(7):1074-083 <a class="external" href="http://dx.doi.org/10.1097/01.ALC.0000130802.07692.29" target="_blank" title="It opens in new window">CrossRefa>
  7. Brumback T, Cao D, King A (2007) Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug and Alcohol Depend 91(1):10-7 <a class="external" href="http://dx.doi.org/10.1016/j.drugalcdep.2007.04.013" target="_blank" title="It opens in new window">CrossRefa>
  8. Clark P, Blissmer B, Greene G (2011) Maintaining exercise and healthful eating in older adults: the SENIOR project II: study design and methodology. Contemp Clin Trials 32:129-39 <a class="external" href="http://dx.doi.org/10.1016/j.cct.2010.10.002" target="_blank" title="It opens in new window">CrossRefa>
  9. Dinges D, Powell J (1985) Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods 17(6):652-55 <a class="external" href="http://dx.doi.org/10.3758/BF03200977" target="_blank" title="It opens in new window">CrossRefa>
  10. Doran S (2001) Sustained attention performance during sleep deprivation: evidence of state instability. Archives Italiennes de Biologie 139(3):253-67
  11. Dry MJ, Burns NR, Nettelbeck T, Farquharson AL, White JM (2012) Dose-related effects of alcohol on cognitive functioning. PloS One 7(11):e50977 <a class="external" href="http://dx.doi.org/10.1371/journal.pone.0050977" target="_blank" title="It opens in new window">CrossRefa>
  12. Dumont GJH, Wezenberg E, Valkenberg MMGJ, De Jong CAJ, Buitelaar JK, Van Gerven JMA, Verkes RJ (2008) Acute neuropsychological effects of MDMA and ethanol (co-) administration in healthy volunteers. Psychopharmacology 197(3):465-74
  13. Dunlap WP, Cortina JM, Vaslow JB, Burke MJ (1996) Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods 1(2):170-77 <a class="external" href="http://dx.doi.org/10.1037/1082-989X.1.2.170" target="_blank" title="It opens in new window">CrossRefa>
  14. Evans SM, Levin FR (2003) Response to alcohol in females with a paternal history of alcoholism. Psychopharmacology 169(1):10-0 <a class="external" href="http://dx.doi.org/10.1007/s00213-003-1474-2" target="_blank" title="It opens in new window">CrossRefa>
  15. Evans SM, Levin FR (2004) Differential response to alcohol in light and moderate female social drinkers. Behav Pharmacol 15(3):167-81
  16. Fan J, McCandliss BD, Sommer T, Raz A, Posner MI (2002) Testing the efficiency and independence of attentional networks. J Cogn Neurosci 14(3):340-47 <a class="external" href="http://dx.doi.org/10.1162/089892902317361886" target="_blank" title="It opens in new window">CrossRefa>
  17. Falleti MG, Maruff P, Collie A, Darby DG, McStephen M (2003) Qualitative similarities in cognitive impairment associated with 24?h of sustained wakefulness and a blood alcohol concentration of 005%. J Sleep Res 12(4):265-74 <a class="external" href="http://dx.doi.org/10.1111/j.1365-2869.2003.00363.x" target="_blank" title="It opens in new window">CrossRefa>
  18. Fillmore M, Carscadden J, Vogel-Sprott M (1998) Alcohol, cognitive impairment and expectancies. J Stud Alcohol Drugs 59(2):174
  19. González-Wilhelm L (2007) Prevalence of alcohol and illicit drugs in blood specimens from drivers involved in traffic law offenses. Systematic review of cross-sectional studies. Traffic Inj Prev 8(2):189-98 <a class="external" href="http://dx.doi.org/10.1080/15389580601188121" target="_blank" title="It opens in new window">CrossRefa>
  20. Greenblatt DJ, Legangneux E, Harmatz JS, Weinling E, Freeman J, Rice K, Zammit GK (2006) Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. J Clin Pharmacol 46(12):1469-480 <a class="external" href="http://dx.doi.org/10.1177/0091270006293303" target="_blank" title="It opens in new window">CrossRefa>
  21. Holdstock L, Wit H (2001) Individual differences in responses to ethanol and d‐amphetamine: a within‐subject study. Alcohol: Clin Exp Res 25(4):540-48 <a class="external" href="http://dx.doi.org/10.1111/j.1530-0277.2001.tb02248.x" target="_blank" title="It opens in new window">CrossRefa>
  22. Houwing S, Hagenzieker M, Mathijssen R (2011) Prevalence of alcohol and other psychoactive substances in drivers in general traffic, part I: general results. Deliverable 223, DRUID (Driving under the Influence of Drugs, Alcohol and Medicines) 6th framework programme. Available at <a href="http://www.druid-project.eu/" class="a-plus-plus">http://www.druid-project.eua>
  23. Howard ME, Jackson ML, Kennedy GA, Swann P, Barnes M, Pierce RJ (2007) The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance. Sleep 30(10):1334-340
  24. International Council on Alcohol Drugs and Traffic Safety (ICADTS) (1999) Guidelines on experimental studies undertaken to determine a medicinal drug’s effect on driving or skills related to driving. Bundes Anstalt fuer Strassenwesen (BASt), Cologne, p 1-3
  25. Jewett ME, Dijk DJ, Kronauer RE, Dinges DF (1999) Dose–response relationship between sleep duration and human psychomotor vigilance and subjective alertness. Sleep 22(2):171-79
  26. Jex HR, McDonnell JD, Phatak AV (1966) A “critical-tracking task for man–machine research related to the operator’s effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA CR, 1-05
  27. Kay G, Logan B (2011) Drugged driving expert panel report: a consensus protocol for assessing the potential of drugs to impair driving. National Highway Traffic Safety Administration, Washington, DC
  28. King? AC,? Byars JA (2004) Alcohol-induced performance impairment in heavy episodic and light social drinkers. J? Stud on Alcohol? Drugs 65(1):27-6
  29. Kleykamp BA, Griffiths RR, Mintzer MZ (2010) Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. Exp Clin Psychopharmacol 18(1):1 <a class="external" href="http://dx.doi.org/10.1037/a0018407" target="_blank" title="It opens in new window">CrossRefa>
  30. Krüger HP (1993) Effects of low alcohol dosages: a review of the literature. In: Utzelmann HD, Berghaus G, Kroj G (eds) Alcohol, drugs and traffic safety—T-2. TüV Rheinland, Cologne, pp 763-78
  31. Kuypers KP, Samyn N, Ramaekers JG (2006) MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function. Psychopharmacology 187(4):467-75 <a class="external" href="http://dx.doi.org/10.1007/s00213-006-0434-z" target="_blank" title="It opens in new window">CrossRefa>
  32. Lacey JH, Kelley-Baker T, Furr-Holden D, Brainard K, Moore C (2009) Pilot test of new roadside survey methodology for impaired driving (No HS-810 704). National Highway Traffic Safety Administration, Washington, DC
  33. Leufkens TRM, Lund JS, Vermeeren A (2009) Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. J Sleep Res 18(4):387-96 <a class="external" href="http://dx.doi.org/10.1111/j.1365-2869.2009.00746.x" target="_blank" title="It opens in new window">CrossRefa>
  34. Leung S, Croft RJ, Jackson ML, Howard ME, McKenzie RJ (2012) A comparison of the effect of mobile phone use and alcohol consumption on driving simulation performance. Traffic Inj Prev 13(6):566-74 <a class="external" href="http://dx.doi.org/10.1080/15389588.2012.683118" target="_blank" title="It opens in new window">CrossRefa>
  35. Louwerens J, Gloerich A, de Vries G, Brookhuis K, O’Hanlon J (1987) The relationship between drivers-blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij PC, Roszbach R (eds) Alcohol Drugs Traffic Safety - T86. Elsevier, Amsterdam, pp 183-86
  36. McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ (2000) Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 22(5):480-92 <a class="external" href="http://dx.doi.org/10.1016/S0893-133X(99)00147-5" target="_blank" title="It opens in new window">CrossRefa>
  37. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14(5):463-66 <a class="external" href="http://dx.doi.org/10.3758/BF03203313" target="_blank" title="It opens in new window">CrossRefa>
  38. Mets MAJ, Volkerts ER, Olivier B, Verster JC (2010) Effect of hypnotic drugs on body balance and standing steadiness. Sleep Med Rev 14(4):259-67 <a class="external" href="http://dx.doi.org/10.1016/j.smrv.2009.10.008" target="_blank" title="It opens in new window">CrossRefa>
  39. Mets MAJ, de Vries JM, de Senerpont Domis LM, Volkerts ER, Olivier B, Verster JC (2011) Next-day effects of ramelteon (8?mg), zopiclone (75?mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep 34(10):1327-334
  40. Michon JA (1989) Explanatory pitfalls and rule-based driver models. Accid; Anal Prev 21(4):341-53 <a class="external" href="http://dx.doi.org/10.1016/0001-4575(89)90025-0" target="_blank" title="It opens in new window">CrossRefa>
  41. Moskowitz H (1973) Laboratory studies of the effects of alcohol on some variables related to driving. J Saf Res 1973(5):185-99
  42. Moskowitz H, Robinson C (1988) Driving-related skills in impairment at low blood alcohol levels. Alcohol, Drugs Traffic Saf 86:79-6
  43. Moskowitz H, Florentino D (2000) A review of the literature on the effects of low doses of alcohol on driving-related skills (No HS-809 028). National Highway Traffic Safety Administration, Washington, DC
  44. Ogden EJD, Moskowitz H (2004) Effects of alcohol and other drugs on driver performance. Traffic Inj Prev 5(3):185-98 <a class="external" href="http://dx.doi.org/10.1080/15389580490465201" target="_blank" title="It opens in new window">CrossRefa>
  45. O’Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18(Suppl 1):121-29 <a class="external" href="http://dx.doi.org/10.1111/j.1365-2125.1984.tb02590.x" target="_blank" title="It opens in new window">CrossRefa>
  46. O’Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB (1982) Diazepam impairs lateral position control in highway driving. Science 217(4554):79-1 <a class="external" href="http://dx.doi.org/10.1126/science.7089544" target="_blank" title="It opens in new window">CrossRefa>
  47. Ramaekers JG (2003) Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatr 64(1):20-9 <a class="external" href="http://dx.doi.org/10.4088/JCP.v64n0106" target="_blank" title="It opens in new window">CrossRefa>
  48. Ramaekers JG, Conen S, de Kam PJ, Braat S, Peeters P, Theunissen EL, Ivgy-May N (2011a) Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype. Psychopharmacology 215(2):321-32 <a class="external" href="http://dx.doi.org/10.1007/s00213-010-2149-4" target="_blank" title="It opens in new window">CrossRefa>
  49. Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G (2011b) Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology 214(2):391-01 <a class="external" href="http://dx.doi.org/10.1007/s00213-010-2042-1" target="_blank" title="It opens in new window">CrossRefa>
  50. Riedel WJ, Mehta MA, Unema PJ (2006) Human cognition assessment in drug research. Curr Pharm Des 12(20):2525-539 <a class="external" href="http://dx.doi.org/10.2174/138161206777698882" target="_blank" title="It opens in new window">CrossRefa>
  51. Robbe H, O’Hanlon J (1995) Acute and subchronic effects of paroxetine 20 and 40?mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 5:35-2 <a class="external" href="http://dx.doi.org/10.1016/0924-977X(94)00130-4" target="_blank" title="It opens in new window">CrossRefa>
  52. Roehrs T, Burduvali E, Bonahoom A, Drake C, Roth T (2003) Ethanol and sleep loss: a “dose-comparison of impairing effects. Sleep 26(8):981-85
  53. Roth T, Mayleben D, Corser BC, Singh NN (2008) Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. Hum Psychopharmacol 23(1):13-0 <a class="external" href="http://dx.doi.org/10.1002/hup.884" target="_blank" title="It opens in new window">CrossRefa>
  54. Schnabel E, Hargutt V, Krüger H (2010) Meta-analysis of empirical studies concerning the effects of alcohol on safe driving. Deliverable 112a, DRUID (Driving under the Influence of Drugs, Alcohol and Medicines) 6th framework programme. Available at <a href="http://www.druid-project.eu/" class="a-plus-plus">http://www.druid-project.eu/a>
  55. Seppala T, Linnoila M, Mattila M (1979) Drugs, alcohol and driving. Drugs 17(5):389 <a class="external" href="http://dx.doi.org/10.2165/00003495-197917050-00008" target="_blank" title="It opens in new window">CrossRefa>
  56. Simons R, Martens M, Ramaekers J, Krul A, Kl?pping-Ketelaars I, Skopp G (2012) Effects of dexamphetamine with and without alcohol on simulated driving. Psychopharmacology 222(3):391-99 <a class="external" href="http://dx.doi.org/10.1007/s00213-011-2549-0" target="_blank" title="It opens in new window">CrossRefa>
  57. Silva MT, Laks J, Engelhardt E (2009) Neuropsychological tests and driving in dementia: a review of the recent literature. Revista da Associa??o Médica Brasileira 55(4):484 <a class="external" href="http://dx.doi.org/10.1590/S0104-42302009000400027" target="_blank" title="It opens in new window">CrossRefa>
  58. Stuster J, Burns M, Büx P (1998) Validation of the standardized field sobriety test battery at BACs below 0.10 percent. National Highway Traffic Safety Administration, Washington, DC
  59. Tiplady B, Hiroz J, Holmes L, Drummond G (2003) Errors in performance testing: a comparison of ethanol and temazepam. J Psychopharmacol 17(1):41-9 <a class="external" href="http://dx.doi.org/10.1177/0269881103017001691" target="_blank" title="It opens in new window">CrossRefa>
  60. Van der Elst WMP, Van Boxtel M, Van Breukelen GJ, Jolles J (2006) The Concept Shifting Test: adult normative data. Psychol Assess 18:424-32 <a class="external" href="http://dx.doi.org/10.1037/1040-3590.18.4.424" target="_blank" title="It opens in new window">CrossRefa>
  61. Vermeeren A, De Gier JJ, O’Hanlon JF (1994) Methodological guidelines for experimental research on medicinal drugs affecting driving performance: an international expert survey. J Traffic Med 22(4):173-74
  62. Vermeeren A, O’Hanlon JF (1998) Fexofenadine’s effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 101(3):306-11 <a class="external" href="http://dx.doi.org/10.1016/S0091-6749(98)70240-4" target="_blank" title="It opens in new window">CrossRefa>
  63. Vermeeren A, Riedel WJ, van Boxtel MP, Darwish M, Paty I, Patat A (2002) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25(2):224-31
  64. Verster JC, Roth T (2011) Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med 4:359-71 <a class="external" href="http://dx.doi.org/10.2147/IJGM.S19639" target="_blank" title="It opens in new window">CrossRefa>
  65. Verster JC, Roth T (2012) Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills. Psychopharmacology 220(2):293-01 <a class="external" href="http://dx.doi.org/10.1007/s00213-011-2484-0" target="_blank" title="It opens in new window">CrossRefa>
  66. Verstraete, A, Knoche, A, Jantos, R, and Skopp, G (2011) Per se limits—methods of defining cut off values for zero tolerance. Deliverable 142, DRUID (Driving under the Influence of Drugs, Alcohol and Medicines) 6th framework programme. Available at <a href="http://www.druid-project.eu/" class="a-plus-plus">http://www.druid-project.eu/a>
  67. Vingilis E, Macdonald S (2002) Review: drugs and traffic collisions. Traffic Inj Prev 3(1):1-1 <a class="external" href="http://dx.doi.org/10.1080/15389580210522" target="_blank" title="It opens in new window">CrossRefa>
  68. Walsh JM, Verstraete AG, Huestis MA, M?rland J (2008) Guidelines for research on drugged driving. Addiction 103(8):1258-268 <a class="external" href="http://dx.doi.org/10.1111/j.1360-0443.2008.02277.x" target="_blank" title="It opens in new window">CrossRefa>
  69. Walsh JM, de Gier JJ, Christopherson AS, Verstraete AG (2004) Drugs and driving. Traffic Inj Prev 5(3):241-53 <a class="external" href="http://dx.doi.org/10.1080/15389580490465292" target="_blank" title="It opens in new window">CrossRefa>
  70. Watson P, Watson I, Batt R (1981) Prediction of blood alcohol concentrations in human subjects; updating the Widmark equation. J Stud Alcohol drugs 42(07):547
  71. Weaver B, Bédard M, McAuliffe J, Parkkari M (2009) Using the Attention Network Test to predict driving test scores. Acc; Anal Prev 41(1):76-3 <a class="external" href="http://dx.doi.org/10.1016/j.aap.2008.09.006" target="_blank" title="It opens in new window">CrossRefa>
  72. Wechsler D (1997) WMS-III: Wechsler memory scale administration and scoring manual. Psychological Corporation, San Antonio
  73. Widmark ?EM (1932) Die theoretischen Grundlagen und die praktische Verwendbarkeit der gerichtlich-medizinischen Alkoholbestimmung. Urban & Schwarzenberg, Berlin?
  74. Zador PL, Krawchuk SA, Voas RB (2000) Alcohol-related relative risk of driver fatalities and driver involvement in fatal crashes in relation to driver age and gender: an update using 1996 data. J Stud Alcohol drugs 61(3):387
  
• 作者单位：Stefan Jongen (1)
  Eric Vuurman (1)
  Jan Ramaekers (1)
  Annemiek Vermeeren (1)
  
  1. Experimental Psychopharmacology Unit, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
  
• ISSN：1432-2072

文摘

Rationale Medication and illicit drugs can have detrimental side effects which impair driving performance. A drug’s impairing potential should be determined by well-validated, reliable, and sensitive tests and ideally be calibrated by benchmark drugs and doses. To date, no consensus has been reached on the issue of which psychometric tests are best suited for initial screening of a drug’s driving impairment potential. Objective The aim of this alcohol calibration study is to determine which performance tests are useful to measure drug-induced impairment. The effects of alcohol are used to compare the psychometric quality between tests and as benchmark to quantify performance changes in each test associated with potentially impairing drug effects. Methods Twenty-four healthy volunteers participated in a double-blind, four-way crossover study. Treatments were placebo and three different doses of alcohol leading to blood alcohol concentrations (BACs) of 0.2, 0.5, and 0.8?g/L. Results Main effects of alcohol were found in most tests. Compared with placebo, performance in the Divided Attention Test (DAT) was significantly impaired after all alcohol doses and performance in the Psychomotor Vigilance Test (PVT) and the Balance Test was impaired with a BAC of 0.5 and 0.8?g/L. The largest effect sizes were found on postural balance with eyes open and mean reaction time in the divided attention and?the psychomotor vigilance test. Conclusions The preferable tests for initial screening are the DAT and the PVT, as these tests were most sensitive to the impairing effects of alcohol and being considerably valid in assessing potential driving impairment.